Dr Matthew Blunt BSc, PhD
Senior Research Fellow, John Goldman Fellow
Dr Matthew Blunt is a Senior Research Fellow within the Faculty of Medicine and is currently a John Goldman Fellow funded by Leukaemia UK.
Dr Blunt completed a PhD in immunology and pharmacology at the University of Bath in 2013, funded by the BBSRC and Novartis. He then studied novel treatment strategies for haematological malignancies in the CRUK Centre in Southampton. This work was published in prestigious journals including in Blood and Leukemia and also led to the award of the Catovsky prize (2014) from the UK CLL forum and the John Marsden Prize (2015 and 2016) from the University of Southampton. He then worked with Professor Salim Khakoo on natural killer cells and the development of novel cancer immunotherapies.
In 2018 Dr Blunt received the Postdoctoral Career Track Award from the University of Southampton and in 2019 he was awarded a John Goldman fellowship from Leukaemia UK.
Qualifications
- BSc, Biological Sciences, University of Reading (2009)
- PhD, University of Bath (2013)
Appointments held
- Senior Research Fellow 2020- Present
- John Goldman Fellow 2020- Present
- Faculty of Medicine Postdoctoral Career Track Award Fellow 2018- Present
- Research Fellow, Clinical and Experimental Sciences Unit, University of Southampton 2017- 2019
- Research Fellow, Cancer Sciences Unit, University of Southampton 2013-2017